Homepage
PR Newswire
Portal
Search
Member List
Help
Hello There, Guest!
Login
Register
Login
Username:
Password:
Lost Password?
Remember me
ValueBuddies.com : Value Investing Forum - Singapore, Hong Kong, U.S.
PR Newswire
Pages (779):
« Previous
1
…
140
141
142
143
144
…
779
Next »
Jump to page:
Date & Time
Title
Mon, 28 Jul 2025 16:33:00 +0800
Beko Scales Up Climate Action with Green Electricity and Refurbishment
Mon, 28 Jul 2025 16:14:00 +0800
FNZ Announces Strategic Partnership with Microsoft to Accelerate the Transformation of the Wealth Management Industry
Mon, 28 Jul 2025 16:11:00 +0800
HCSA Community Services and Tan Tock Seng Hospital Sign MOU to Hepatitis C Elimination in Singapore
Mon, 28 Jul 2025 16:10:00 +0800
Doosan Robotics Accelerates Push to Become an AI Robot Solutions Leader
Mon, 28 Jul 2025 15:45:00 +0800
Beijing Review: The Across the Pacific: China-U.S. Youth Dialogue for a Shared Future program concluded in Shanghai.
Mon, 28 Jul 2025 15:43:00 +0800
Fuku AI Responds to Tech Layoffs in Singapore with Scalable AI Recruitment Platform
Mon, 28 Jul 2025 15:28:00 +0800
The 2025 China-ASEAN Education Cooperation Week Held in Guizhou
Mon, 28 Jul 2025 15:27:00 +0800
The 2025 China-ASEAN Education Cooperation Week Held in Guizhou
Mon, 28 Jul 2025 15:20:00 +0800
Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis
Mon, 28 Jul 2025 14:00:00 +0800
Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'
Mon, 28 Jul 2025 13:53:00 +0800
Latest Mouser Series Navigates the Balance of AI and Human Expertise in Engineering
Mon, 28 Jul 2025 13:39:00 +0800
SCO media, think tank summit highlights Shanghai Spirit for enhanced exchange
Mon, 28 Jul 2025 12:17:00 +0800
MALAYSIA HEALTHCARE TRAVEL COUNCIL LAUNCHES MYMT 2026, MALAYSIA'S FIRST MEDICAL TOURISM YEAR
Mon, 28 Jul 2025 12:14:00 +0800
NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer
Mon, 28 Jul 2025 12:02:00 +0800
VT MARKETS CHAMPIONS GROWTH IN ASIA THROUGH PARTNERSHIP WITH NEWCASTLE UNITED AS CSR INITIATIVES ARE LAUNCHED
Mon, 28 Jul 2025 11:26:00 +0800
Infobip named a Leader in 2025 Gartner® Magic Quadrant™ for Communications Platform-as-a-Service for the third consecutive year
Mon, 28 Jul 2025 11:01:00 +0800
CBD Guangzhou 2025 Wraps Up with International Attendance Rising by 47.22%
Mon, 28 Jul 2025 10:40:00 +0800
SMU issues its inaugural Sustainability Bond, raising S$150 million to advance environmental and social initiatives
Mon, 28 Jul 2025 10:40:00 +0800
Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025
Mon, 28 Jul 2025 10:35:00 +0800
Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug
Pages (779):
« Previous
1
…
140
141
142
143
144
…
779
Next »
Jump to page: